Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells

Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells

US Patent 6479261 · Granted Nov 12, 2002

Estimated economic value: $221,205,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds for the inhibition of PASK2022
Controlled release oral pharmaceutical dosage forms comprising MGBG2021
Heterocyclic compounds for the inhibition of PASK2020
Methods and compositions for treatment of demyelinating diseases2019
Method of treatment with anti-inflammatory and analgesic compounds which are GI-2019
Methods and compositions for treatment of demyelinating diseases2018
Heterocyclic compounds for the inhibition of PASK2018
Method of treatment with anti-inflammatory and analgesic compounds which are GI-2017
Controlled release oral pharmaceutical dosage forms comprising MGBG2017
Pharmaceutical for oral delivery comprising MGBG and methods of treating disease2017
Heterocyclic compounds for the inhibition of PASK2015
Heterocyclic compounds for the inhibition of PASK2014